申请人:Sun Chongqing
公开号:US20100048612A1
公开(公告)日:2010-02-25
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formula:
including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein A, B, R
1
, R
2
, R
3
and R
8
are described herein.
本申请描述了按照公式I的化合物,包括至少一种按照公式I的化合物的制药组合物和可选地包括一个或多个额外治疗剂的制药组合物,并且使用按照公式I的化合物单独或与一个或多个额外治疗剂联合使用的治疗方法。这些化合物具有以下通用公式:包括所有的前药、溶剂化物、药学上可接受的盐和立体异构体,其中A、B、R1、R2、R3和R8如本文所述。